Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Susan Ringdal. Insider active across 1 company, notably Hikma Pharmaceuticals PLC. In total, 16 disclosures have been logged. Activity tracked since 10 August 2023. The latest transaction was disclosed on 1 June 2026 (Vesting). Regulator: RNS (LSE). The full history is accessible without signup.
Companies and markets linked to Susan Ringdal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
0100.0% of flowLondon Stock Exchange (XLON)ISINISIN GB00B0LCW083RNS:4866472
16 of 16 declarations
About Susan Ringdal
Susan Ringdal is a declarant linked to Hikma Pharmaceuticals PLC (XLON), where she is a PDMR. She has 16 filings in total, and across the 16 sampled filings the buy volume is EUR 118936 and the sell volume is EUR 713327, over the period from 2023-08-11 to 2026-06-05. The modal transaction nature is Vesting.